National Bank Of Canada Ionis Pharmaceuticals Inc Transaction History

National Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $3,362 - $4,284	80 New	80 $3,000
Q4 2022 Jan 24, 2023	BUY	$37.12 - $46.52 $340,576 - $426,821	9,175 Added 17.74%	60,895 $0
Q3 2022 Oct 13, 2022	BUY	$36.54 - $48.66 $1.89 Million - $2.52 Million	51,720 New	51,720 $2.29 Million
Q1 2022 May 05, 2022	SELL	$29.88 - $37.04 $2.09 Million - $2.59 Million	-70,000 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$25.61 - $35.1 $1.79 Million - $2.46 Million	70,000 New	70,000 $2.13 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.